There is considerable evidence, both in humans and animals that IFN-γ production is necessary for protective immunity against mycobacterial disease [18]–[21] and successful chemotherapy of TB is associated with augmented IFN-γ production [22]–[24]. The gene discussed is IFNG; the disease is tuberculosis.